Cocrystallization of Gefitinib Potentiate Single-Dose Oral Administration for Lung Tumor Eradication via Unbalancing the DNA Damage/Repair.

MLA

Inam, Muhammad, et al. “Cocrystallization of Gefitinib Potentiate Single-Dose Oral Administration for Lung Tumor Eradication via Unbalancing the DNA Damage/Repair.” Pharmaceutics, vol. 15, no. 12, Dec. 2023, p. 2713. EBSCOhost, https://doi.org/10.3390/pharmaceutics15122713.

APA

Inam, M., Yang, Y., Hu, J., Zheng, J., Deng, W., Zhou, Y., Qi, J., Xu, C., Chai, G., Dang, Y., & Chen, W. (2023). Cocrystallization of Gefitinib Potentiate Single-Dose Oral Administration for Lung Tumor Eradication via Unbalancing the DNA Damage/Repair. Pharmaceutics, 15(12), 2713. https://doi.org/10.3390/pharmaceutics15122713

Chicago

Inam, Muhammad, Yi Yang, Jialin Hu, Jiena Zheng, Wenxia Deng, You Zhou, Jialong Qi, et al. 2023. “Cocrystallization of Gefitinib Potentiate Single-Dose Oral Administration for Lung Tumor Eradication via Unbalancing the DNA Damage/Repair.” Pharmaceutics 15 (12): 2713. doi:10.3390/pharmaceutics15122713.